ArticleCancer management and research2018

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.

Wenjie Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.